PPAPDC3 activators are a diverse group of compounds that exert their influence via various biochemical mechanisms, ultimately leading to the increased activity of this lipid phosphatase. For example, certain activators work by binding to and activating adenylate cyclase, which in turn increases intracellular cAMP levels. This rise in cAMP can enhance the functional activity of PPAPDC3 by altering lipid signaling pathways, a process that is crucial for maintaining cellular homeostasis. Other activators directly engage with protein kinase C, leading to the phosphorylation of proteins that are part of the signaling cascades in which PPAPDC3 is involved. This phosphorylation can modify the activity of PPAPDC3, integrating it more effectively into cellular signaling.
Some activators influence intracellular calcium levels, which is a key factor in various signaling pathways, including those that could affect PPAPDC3. By mobilizing calcium stores or facilitating calcium influx into the cell, these activators indirectly modulate the activity of PPAPDC3 within calcium-mediated phospholipid signaling pathways. Alternatively, certain sphingosine analogs and sphingosine-1-phosphate activators can modulate sphingolipid signaling pathways, impacting PPAPDC3 function. Other compounds can increase intracellular NAD+ levels, which, while not directly interacting with PPAPDC3, could influence its activity through alterations in cellular metabolism. Additionally, some activators can modify the eicosanoid synthesis pathway, which is closely related to phospholipid signaling, thereby indirectly affecting PPAPDC3's role within these pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate proteins in pathways that PPAPDC3 is involved in. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium, potentially affecting calcium-dependent phospholipid signaling involving PPAPDC3. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Mobilizes intracellular calcium stores, indirectly influencing PPAPDC3 activity in calcium-mediated pathways. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that raises cAMP levels, thereby possibly enhancing PPAPDC3 activity through lipid signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases, elevating cAMP and potentially increasing PPAPDC3 activity via lipid signaling pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
cAMP analog that bypasses receptors and directly activates cAMP-dependent pathways, potentially activating PPAPDC3. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
Sphingosine analogue that after phosphorylation can influence sphingosine-1-phosphate (S1P) signaling impacting PPAPDC3. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Activates S1P receptors, potentially influencing PPAPDC3 function in sphingolipid signaling pathways. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Raises intracellular levels of nicotinamide adenine dinucleotide (NAD+), which could indirectly affect PPAPDC3 activity. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Precursor in eicosanoid synthesis, can modulate phospholipid signaling pathways that involve PPAPDC3. | ||||||